A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic.

Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. (1/24)

Pancreatic proteases are secreted in acute pancreatitis, but their contribution to associated lung injury is unclear. Applying models of mild edematous (intravenous caerulein) and severe necrotizing (intraductal glycodeoxycholic acid) pancreatitis in rats, we showed that both trypsinogen and trypsin concentrations in peripheral blood, as well as lung injury, correlate with the severity of the disease. To isolate the potential contribution of proteases to lung injury, trypsin or trypsinogen was injected into healthy rats or trypsinogen secreted in caerulein pancreatitis was activated by intravenous enterokinase. Pulmonary injury induced by protease infusions was dose dependent and was ameliorated by neutrophil depletion. Trypsinogen activation worsened lung injury in mild pancreatitis. In vitro incubation of leukocytes with trypsinogen showed that stimulated leukocytes can convert trypsinogen to trypsin. In conclusion, this study demonstrates that the occurrence and severity of pancreatitis-associated lung injury (PALI) corresponds to the levels of circulating trypsinogen and its activation to trypsin. Neutrophils are involved in both protease activation and development of pulmonary injury.  (+info)

Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture. (2/24)

Bile acid-induced inhibition of DNA synthesis by the regenerating rat liver in the absence of other manifestation of impairment in liver cell viability has been reported. Because in experiments carried out on in vivo models bile acids are rapidly taken up and secreted into bile, it is difficult to establish steady concentrations to which the hepatocytes are exposed. Thus, in this work, a dose-response study was carried out to investigate the in vitro cytotoxic effect of major unconjugated and tauro- (T) or glyco- (G) conjugated bile acids and to compare this as regards their ability to inhibit DNA synthesis. Viability of hepatocytes in primary culture was measured by Neutral red uptake and formazan formation after 6 h exposure of cells to bile acids. The rate of DNA synthesis was determined by radiolabeled thymidine incorporation into DNA. Incubation of hepatocytes with different bile acid species - cholic acid (CA), deoxycholic acid (DCA), chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA), in the range of 10-1000 microM - revealed that toxicity was stronger for the unconjugated forms of CDCA and DCA than for CA and UDCA. Conjugation markedly reduced the effects of bile acids on cell viability. By contrast, the ability to inhibit radiolabeled thymidine incorporation into DNA was only slightly lower for taurodeoxycholic acid (TDCA) and glycodeoxycholic acid (GDCA) than for DCA. When the effect of these bile acids on DNA synthesis and cell viability was compared, a clear dissociation was observed. Radiolabeled thymidine incorporation into DNA was significantly decreased (-50%) at TDCA concentrations at which cell viability was not affected. Lack of a cause-effect relationship between both processes was further supported by the fact that well-known hepatoprotective compounds, such as tauroursodeoxycholic acid (TUDCA) and S-adenosylmethionine (SAMe) failed to prevent the effect of bile acids on DNA synthesis. In summary, our results indicate that bile acid-induced reduction of DNA synthesis does not require previous decreases in hepatocyte viability. This suggests the existence of a high sensitivity to bile acids of cellular mechanisms that may affect the rate of DNA repair and/or proliferation, which is of particular interest regarding the role of bile acids in the etiology of certain types of cancer.  (+info)

cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release. (3/24)

We have previously shown that cAMP protects against bile acid-induced apoptosis in cultured rat hepatocytes in a phosphoinositide 3-kinase (PI3K)-dependent manner. In the present studies, we investigated the mechanisms involved in this anti-apoptotic effect. Hepatocyte apoptosis induced by glycodeoxycholate (GCDC) was associated with mitochondrial depolarization, activation of caspases, the release of cytochrome c from the mitochondria, and translocation of BAX from the cytosol to the mitochondria. cAMP inhibited GCDC-induced apoptosis, caspase 3 and caspase 9 activation, and cytochrome c release in a PI3K-dependent manner. cAMP activated PI3K in p85 immunoprecipitates and resulted in PI3K-dependent activation of the survival kinase Akt. Chemical inhibition of Akt phosphorylation with SB-203580 partially blocked the protective effect of cAMP. cAMP resulted in wortmannin-independent phosphorylation of BAD and was associated with translocation of BAD from the mitochondria to the cytosol. These results suggest that GCDC-induced apoptosis in cultured rat hepatocytes proceeds through a caspase-dependent intracellular stress pathway and that the survival effect of cAMP is mediated in part by PI3K-dependent Akt activation at the level of the mitochondria.  (+info)

Pulmonary injury in acute experimental pancreatitis correlates with elevated levels of free fatty acids in rats. (4/24)

Since some authors have stated a certain role for so-called "free fatty acids" (FFA) in the pathogenesis of AP and the subsequent systemic complications we tried to find possible correlations between FFA, pancreatitis and lung injury using a rat model. AP was induced by intraductal infusion of two different concentrations of glycodeoxycholic acid (GDOC 17 mmol and 34 mmol). An equal number of animals had only cannulation of the pancreatic duct without infusion and served as controls (GDOC-control). In another experimental model iv.-infusion of oleic acid (OA) was used to create severe lung injury comparable to human ARDS. In this model control animals received iv.-infusion of saline solution only (SAL). At 2, 6, 12, 24 and 48 hours the animals were sacrificed and blood was collected for determination of FFA, amylase and pO2. The pancreas and lungs were removed for histologic examination and the lungs were weighed. GDOC-34 animals developed severe pancreatitis with hemorrhage and necrosis. Histology of the lungs showed edema, inflammatory infiltrates, hemorrhage and thickening of the alveolar membrane in GDOC-34 rats as well as in OA-animals. In contrast, there was only pancreatic edema until 24 hours in the GDOC 17 group and less severe histological changes in the lungs. Amylase, FFA, pO2 and lung weight were directly influenced by the different kinds of treatment. Furthermore, FFA correlated positively with the levels of amylase and lung weight and negatively with pO2. Infusion of OA alone also caused an increase in levels of amylase with pancreatic edema and focal necroses in some animals. These results show that it was possible to create different degrees of severity of AP which was in concordance with different degrees of morphologic changes and dysfunction in the lungs. FFA values correlated significantly with the clinical course as well as with increasing amylase, lung weight and decreasing pO2.  (+info)

Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats. (5/24)

The selective estrogen receptor modulators tamoxifen and raloxifene represent a major therapeutic advance for clinical practice. Unlike estrogens, which are uniformly agonists, tamoxifen and raloxifene exert selective agonistic or antagonistic effects on various estrogen target tissues. The aim of the study was to evaluate the influence of tamoxifen and raloxifene on the conversion of cholesterol to bile acids in estrogen deficiency in rats. The study included 40 female Wistar rats. The animals were divided into four groups: sham operated control, ovariectomized control, ovariectomized rats treated with tamoxifen ovariectomized rats treated with raloxifene. After 42 days of drug administration, bile was collected under anesthesia after administration of radioactive 4-(14)C cholesterol. Bile was assayed for concentration of (14)C bile acids conjugated with taurine and glycine after thin-layer chromatography separation by the use of isotopic technique. In rats treated with tamoxifen and raloxifene, the statistically significant increase in concentration of bile acids conjugated with glycine was observed as compared to ovariectomized animals from control group. Moreover, in rats treated with tamoxifen the concentration of bile acids conjugated with taurine significantly increased. The results of the present study suggest that tamoxifen and raloxifene increase the concentrations of conjugated bile acids in bile.  (+info)

Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. (6/24)

In acute pancreatitis, local as well as systemic organ complications are mediated by the activation of various inflammatory cascades. The role of complement in this setting is unclear. The aim of the present study was to determine the level of complement activation in experimental pancreatitis, to evaluate the interaction of complement and leukocyte-endothelium activation, and to assess the effects of complement inhibition by soluble complement receptor 1 (sCR1) in this setting. Necrotizing pancreatitis was induced in Wistar rats by the combination of intravenous cerulein and retrograde infusion of glycodeoxycholic acid into the biliopancreatic duct; edematous pancreatitis was induced by intravenous cerulein only. In control animals, a sham operation (midline laparotomy) was performed. Complement activation, leukocyte sequestration, and pancreatic as well as pulmonary injury were assessed in the presence/absence of sCR1. Increased levels of C3a were found in necrotizing but not in edematous pancreatitis. When complement activation in necrotizing pancreatitis was blocked by sCR1, levels of C3a and total hemolytic activity (CH50) were decreased. Leukocyte-endothelial interaction, as assessed by intravital microscopy, and pancreatic as well as pulmonary organ injury (wet-to-dry weight ratio, MPO activity, and histology) were ameliorated by sCR1. As a result of the present study, necrotizing but not edematous pancreatitis is characterized by significant and early complement activation. Based on the interaction of complement and leukocytes, complement inhibition by sCR1 may be a valuable option in the treatment of leukocyte-associated organ injury in severe pancreatitis.  (+info)

A better model of acute pancreatitis for evaluating therapy. (7/24)

Existing models of acute pancreatitis have limitations to studying novel therapy. Whereas some produce mild self-limited pancreatitis, others result in sudden necrotizing injury. The authors developed an improved model providing homogeneous moderately severe injury by superimposing secretory hyperstimulation on minimal intraductal bile acid exposure. Sprague-Dawley rats (n = 231) received low-pressure intraductal glycodeoxycholic acid (GDOC) at very low (5 or 10 mmol/L) concentrations followed by intravenous cerulein. Cerulein or GDOC alone caused only very mild inflammation. However, GDOC combined with cerulein was uniformly associated with more edema (p less than 0.0005), acinar necrosis (p less than 0.01), inflammation (p less than 0.006), and hemorrhage (p less than 0.01). Pancreatic injury was further increased and death was potentiated by increasing volume and duration of intraductal low-dose GDOC infusion. There was significant morphologic progression between 6 and 24 hours. The authors conclude that (1) combining minimal intraductal bile acid exposure with intravenous hyperstimulation produces homogeneous pancreatitis of intermediate severity that can be modulated at will; (2) the injury is progressive over at least 24 hours with finite mortality rate; (3) the model provides superior opportunity to study innovative therapy.  (+info)

Biosynthesis of bile acids in a variety of marine bacterial taxa. (8/24)

Several marine bacterial strains, which were isolated from seawater off the island Dokdo, Korea, were screened to find new bioactive compounds such as antibiotics. Among them, Donghaeana dokdonensis strain DSW-6 was found to produce antibacterial agents, and the agents were then purified and analyzed by LC-MS/MS and 1D- and 2D-NMR spectrometries. The bioactive compounds were successfully identified as cholic acid and glycine-conjugated glycocholic acid, the 7alpha-dehydroxylated derivatives (deoxycholic acid and glycodeoxycholic acid) of which were also detected in relatively small amounts. Other masine isolates, taxonomically different from DSW-6, were also able to produce the compounds in a quite different production ratio from DSW-6. As far as we are aware of, these bile acids are produced by specific members of the genus Streptomyces and Myroides, and thought to be general secondary metabolites produced by a variety of bacterial taxa that are widely distributed in the sea.  (+info)

Glycodeoxycholic acid (GDCA) is not a widely recognized or established medical term. However, it appears to be a chemical compound that can be formed as a result of the metabolic process in the body. It is a glycine-conjugated bile acid, which means that it is a combination of the bile acid deoxycholic acid and the amino acid glycine.

Bile acids are produced by the liver to help with the digestion and absorption of fats in the small intestine. They are conjugated, or combined, with amino acids like glycine or taurine before being released into the bile. These conjugated bile acids help to keep the bile acid salts in their soluble form and prevent them from being reabsorbed back into the bloodstream.

Glycodeoxycholic acid may be involved in various physiological processes, but there is limited research on its specific functions or medical significance. If you have any concerns about this compound or its potential impact on your health, it would be best to consult with a healthcare professional for more information.

Glycodeoxycholic acid is a bile acid derived from deoxycholic acid and glycine. Except where otherwise noted, data are given ... Bile acids, Cholanes, All stub articles, Steroid stubs). ...
Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and ... Deoxycholic acid; TCA: Taurocholic acid; GCA: Glycocholic acid; TDCA: Taurodeoxycholic acid; GDCA: Glycodeoxycholic acid; TCDCA ... CA: Cholic acid; CDCA: Chenodeoxycholic acid; DCA: Deoxycholic acid; GCA: Glycocholic acid; GCDCA: Glycochenodeoxycholic acid; ... CA: Cholic acid; CDCA: Chenodeoxycholic acid; DCA: Deoxycholic acid; GCA: Glycocholic acid; GCDCA: Glycochenodeoxycholic acid; ...
Specifically, only the levels of the bile acid (BA) metabolites (glycodeoxycholic acid) and prostaglandin B2 (PGB2) were ... Metabolites from arachidonic acid (essential fatty acids), including prostaglandins, thromboxanes and leukotrienes, were ... Lastly, metabolic profiling showed that arachidonic acid, prostaglandins, and palmitic acid were enriched at 48H. This study ... of formic acid in water, and (B) with 0.1% of formic acid in acetonitrile. Data analysis was performed using a targeted ...
glycocholic acid-d4 glycodeoxycholic acid-2,2,4,4-d4 glycyl group ... 3-(trimethylsilyl)-1-propanesulfonic acid-d6 3-[beta-D-glucopyranosyl-(1->6)-beta-D-galactopyranosyl]-1,2-dipalmitoyl-16,16,16- ...
... and are able to conjugate alternative amino acids to provide custom products as required. ... We supply conjugates to a host of bile acids, ... ICE959 Glycodeoxycholic acid View product. ICE960 ... Bile Acid Conjugates. Bile acids are naturally coupled to either glycine or taurine in the liver to form bile salt conjugates. ... ICE Pharma are able to supply these conjugates to a host of bile acids and we are able to conjugate alternative amino acids to ...
... glycolithocholic acid, and taurolithocholic acid (TLCA) and a negative association with glycodeoxycholic acid. However, the ... taurodeoxycholic acid, CA, and DCA in bile and its metabolites in the liver, tauro-α-muricholic acid, tauroursodeoxycholic acid ... lithocholic acid. MCA. muricholic acid. NAFLD. nonalcoholic fatty liver disease. NASH. nonalcoholic steatohepatitis. NTCP. ... cholic acid. CAR. constitutive androstane receptor. CDCA. chenodeoxycholic acid. CYP27A1. sterol 27-hyroxylase. CYP7A1. ...
C3R inhibited the formation of cholesterol micelles and bound to primary and secondary bile acid. In Caco-2 cells, C3R (12.5- ... The bile acid binding was measured using the colorimetric assay. The NBD cholesterol uptake in Caco-2 cells was determined ... Bile acid binding. The percentage of taurocholic acid, taurodeoxycholic acid and glycodeoxycholic acid binding capacity of C3R ... Glycodeoxycholic acid, taurodeoxycholic acid and taurocholic acid were used as bile acid in this experiment. Briefly, various ...
... glycodeoxycholic acid, inosine, and alpha-ketoglutarate). In contrast, multiple acyl-lyso-phosphatidylcholine metabolites were ... glycodeoxycholic acid, inosine, and alpha-ketoglutarate). In contrast, multiple acyl-lyso-phosphatidylcholine metabolites were ... glycodeoxycholic acid, inosine, and alpha-ketoglutarate). In contrast, multiple acyl-lyso-phosphatidylcholine metabolites were ... glycodeoxycholic acid, inosine, and alpha-ketoglutarate). In contrast, multiple acyl-lyso-phosphatidylcholine metabolites were ...
The main advantage of bile acids is their ability to act as both drug-solubilizing and permeation-modifying agents. Besides ... The availability and low cost of bile acids along with their unique advantages turn them into attractive scaffolds for the ... In recent years, bile acids and their derivatives have received considerable interest in drug delivery research due to their ... Glycodeoxycholic acid360-65-6. Glycohyodeoxycholic acid13042-33-6. Glycohyodeoxycholic acid sodium salt38411-84-6 ...
Glycodeoxycholic Acid 18% 2 Scopus citations * Acute Liver Failure Guidelines. Shingina, A., Mukhtar, N., Wakim-Fleming, J., ...
12α-Dihydroxy-5β-cholanic acid,7-Deoxycholic acid,Desoxycholic acid; find Sigma-Aldrich-30960 MSDS, related peer-reviewed ... Deoxycholic acid ≥99.0% (T); CAS Number: 83-44-3; EC Number: 201-478-5; Synonyms: 3α, ... 3α,12α-Dihydroxy-5β-cholanic acid, 7-Deoxycholic acid, Desoxycholic acid ... Deoxycholic acid is an amphiphilic molecule and an important constituent of bile acid. It contains hydroxyl groups substituted ...
4. Reduced glycodeoxycholic acid levels..... 5. FLT3 and NPM1 mutations in Chinese..... 6. Effect of intensive multifactorial ...
... whereas glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, glycolithocholic acid, and glycoursodeoxycholic acid ... whereas glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, glycolithocholic acid, and glycoursodeoxycholic acid ... whereas glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, glycolithocholic acid, and glycoursodeoxycholic acid ... whereas glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, glycolithocholic acid, and glycoursodeoxycholic acid ...
Glycodeoxycholic Acid Medicine & Life Sciences 100% * rho-Associated Kinases Medicine & Life Sciences 70% ... Jadeja RN, Thounaojam MC, Bartoli M, Khurana S. Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by ... Jadeja, R. N., Thounaojam, M. C., Bartoli, M., & Khurana, S. (2018). Deoxycholylglycine, a conjugated secondary bile acid, ... Jadeja, RN, Thounaojam, MC, Bartoli, M & Khurana, S 2018, Deoxycholylglycine, a conjugated secondary bile acid, reduces ...
To the best of our knowledge, short-chain fatty acids (SCFAs), bile salt hydrolase (BSH), metabolic endotoxemia and the ... It was reported that BSH activity could hydrolyze conjugated glycodeoxycholic acid and taurodeoxycholic acid, leading to the ... When bile acid enters the enterohepatic circulation, probiotics hydrolyze the bile acid and bile salts through hydroxysteroid ... volatile fatty acids and chemically modified bile acids. In this way, the indigenous gut bacteria are able to modify adverse ...
Bile acid levels were higher in CF patients than in HS, except for glycodeoxycholic acid (GDCA). However, bile acid ... Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease. ... GDCA and deoxycholic acid (DCA) differentiated CF patients with non-cirrhotic liver disease from those without liver disease ( ... BACKGROUND: Cystic fibrosis (CF) and CF-related liver disease can lead to disturbances in bile acid metabolism. AIM: This study ...
... induced by glycodeoxycholic acid in rats. The induction of ANP resulted in significant increase in mortality rate, pancreatic ...
Similar levels of IL-1ra could be detected in serum over the same time scales (24). Using glycodeoxycholic acid ductal infusion ... In rat bile-acid infusion AP model, IL-10 rises from a baseline of 10 pg/ml to 5000 pg/ml after 6 h, earlier than the pro- ... In rat bile-acid induced AP, for example, free TNFa increased from 3 pg/ml to 7.5 pg/ml within an hour, only to return to ... Plasma levels in rats with bile-acid induced AP rise from 20 pg/ml to a peak of 80 pg/ml within 24 h (100). ...
Glycodeoxycholic Acid *Gsk3 Alpha *Hama Antibodies *Hdac Activity Assay *Isotypes *Laminin Alpha 5 ...
Glycodeoxycholic Acid. *Gsk3 Alpha. *Hama Antibodies. *Hdac Activity Assay. *Isotypes. *Laminin Alpha 5 ...
In Glycodeoxycholic Acid-d4 custom synthesis contrast, DARPin is well-expressed inside the cells [45], particularly AnkGAG 1D4 ...
2021, 11,11 ofA minicomputer (Raspberry Pi v3) was Glycodeoxycholic Acid-d4 MedChemExpress utilized to execute device ...
Glycocholic Acid D4.808.105.225.400 D4.210.500.105.225.400 D4.808.221.430.484 D4.210.500.221.430.484 Glycodeoxycholic Acid ... Amino Acid Transport System y+ D12.776.157.530.937.375 D12.776.543.585.937.375 Amino Acid Transport System y+L D12.776.157.530. ... Amino Acid Motifs G2.111.570.60.40 G2.111.570.820.709.275.500 G2.111.570.820.709.600.40 G2.111.570.820.709.600.500 Amino Acid ... Acid Rain G16.500.240.135.859.50 G16.500.175.859.50 Acid Sensing Ion Channels D12.776.543.550.425.875.50 D12.776.543.550. ...
Glycocholic Acid D4.808.105.225.400 D4.210.500.105.225.400 D4.808.221.430.484 D4.210.500.221.430.484 Glycodeoxycholic Acid ... Amino Acid Transport System y+ D12.776.157.530.937.375 D12.776.543.585.937.375 Amino Acid Transport System y+L D12.776.157.530. ... Amino Acid Motifs G2.111.570.60.40 G2.111.570.820.709.275.500 G2.111.570.820.709.600.40 G2.111.570.820.709.600.500 Amino Acid ... Acid Rain G16.500.240.135.859.50 G16.500.175.859.50 Acid Sensing Ion Channels D12.776.543.550.425.875.50 D12.776.543.550. ...
Glycocholic Acid D4.808.105.225.400 D4.210.500.105.225.400 D4.808.221.430.484 D4.210.500.221.430.484 Glycodeoxycholic Acid ... Amino Acid Transport System y+ D12.776.157.530.937.375 D12.776.543.585.937.375 Amino Acid Transport System y+L D12.776.157.530. ... Amino Acid Motifs G2.111.570.60.40 G2.111.570.820.709.275.500 G2.111.570.820.709.600.40 G2.111.570.820.709.600.500 Amino Acid ... Acid Rain G16.500.240.135.859.50 G16.500.175.859.50 Acid Sensing Ion Channels D12.776.543.550.425.875.50 D12.776.543.550. ...
Glycocholic Acid D4.808.105.225.400 D4.210.500.105.225.400 D4.808.221.430.484 D4.210.500.221.430.484 Glycodeoxycholic Acid ... Amino Acid Transport System y+ D12.776.157.530.937.375 D12.776.543.585.937.375 Amino Acid Transport System y+L D12.776.157.530. ... Amino Acid Motifs G2.111.570.60.40 G2.111.570.820.709.275.500 G2.111.570.820.709.600.40 G2.111.570.820.709.600.500 Amino Acid ... Acid Rain G16.500.240.135.859.50 G16.500.175.859.50 Acid Sensing Ion Channels D12.776.543.550.425.875.50 D12.776.543.550. ...
Glycocholic Acid D4.808.105.225.400 D4.210.500.105.225.400 D4.808.221.430.484 D4.210.500.221.430.484 Glycodeoxycholic Acid ... Amino Acid Transport System y+ D12.776.157.530.937.375 D12.776.543.585.937.375 Amino Acid Transport System y+L D12.776.157.530. ... Amino Acid Motifs G2.111.570.60.40 G2.111.570.820.709.275.500 G2.111.570.820.709.600.40 G2.111.570.820.709.600.500 Amino Acid ... Acid Rain G16.500.240.135.859.50 G16.500.175.859.50 Acid Sensing Ion Channels D12.776.543.550.425.875.50 D12.776.543.550. ...
... as well as the blend of glycodeoxycholic acid solution (15 mmol/L, One.0 mL/kg, intraductal infusion) as well as cerulein (Your ... Just about all rights set-aside.The goal of the analysis was to determine the actual amino acid structure in fillet proteins ... Powerful organizations between alternatives from the man genes fatty acid desaturase A single (FADS1, computer programming ... put together pertaining to arachidonic acid solution (30:4n-6), the key forerunners associated with eicosanoids. Themes ...
The use of an integrated analysis showed that the reduction of plasma glycolithocholic acid and taurolithocholic acid could ... The results of metagenomic sequencing and targeted metabolome analysis together revealed that secondary bile acid (SBA) ... UDCA ursodeoxycholic acid, DCA deoxycholic acid, LCA lithocholic acid, ApoCA apocholic acid, GDCA glycodeoxycholic acid, 7-KDCA ... Deoxycholic acid; LCA: Lithocholic acid; ApoCA: Apocholic acid; GDCA: Glycodeoxycholic acid; 7-KDCA: 7-ketodeoxycholic acid; 7- ...
... high amounts of primary bile acids as well as sterols were found in their feces. By finding peculiar gut microbiome profiles ... especially of genes involved in secondary bile acid biosynthesis and neuroendocrine signaling (i.e., production of ... CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; GCA, glycocholic acid; GDCA, glycodeoxycholic acid; HDCA, ... Free bile acids ursodeoxycholic acid (UDCA), chenodeoxycholic acid (CDCA), cholic acid (CA), deoxycholic acid (DCA), and ...
  • Subsequent enzymatic reactions catalyzed by sterol 12 α -hydroxylase (CYP8B1) and sterol 27-hyroxylase (CYP27A1), respectively, yield the primary BAs, cholic acid (CA) and chenodeoxycholic acid (CDCA). (aspetjournals.org)
  • Chenodeoxycholic acid NEW! (viochemicals.com)
  • Results: In the overall study population, serum cholic acid and chenodeoxycholic acid were lower, whereas glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, glycolithocholic acid, and glycoursodeoxycholic acid were significantly higher at older ages. (johnshopkins.edu)
  • An epimer of chenodeoxycholic acid. (nih.gov)
  • In addition, C3R inhibited the formation of cholesterol micelles and bound to primary and secondary bile acid. (biomedcentral.com)
  • The results of metagenomic sequencing and targeted metabolome analysis together revealed that secondary bile acid (SBA) biosynthesis was significantly activated in the cows with excessive lipolysis. (biomedcentral.com)
  • which exhibited low transcriptional activity, especially of genes involved in secondary bile acid biosynthesis and neuroendocrine signaling (i.e., production of neurotransmitters, indoles and ligands for cannabinoid receptors). (biomedcentral.com)
  • Glycodeoxycholic acid is a bile acid derived from deoxycholic acid and glycine. (wikipedia.org)
  • Deoxycholic acid NEW! (viochemicals.com)
  • Deoxycholic acid is an amphiphilic molecule and an important constituent of bile acid. (sigmaaldrich.com)
  • High levels of intestinal deoxycholic acid might cause colorectal cancer by inducing oxidative stress and leading to DNA damage. (sigmaaldrich.com)
  • Serum bile acids were measured using stable-isotope liquid chromatography-tandem mass spectrometry. (johnshopkins.edu)
  • Independent of age, serum taurochenodeoxycholic acid, tauromuricholic acid, and glycoursodeoxycholic acid were significantly different between 244 children with EED and 69 children without EED. (johnshopkins.edu)
  • Total serum bile acids (median, interquartile range) were 4.51 (2.45, 7.51) and 5.10 (3.32, 9.01) μmol/L in children with and without EED, respectively (age-adjusted, P=0.0009). (johnshopkins.edu)
  • Bile acids are naturally coupled to either glycine or taurine in the liver to form bile salt conjugates. (thebileacidsexpert.com)
  • Glycolithocholic acid NEW! (viochemicals.com)
  • The use of an integrated analysis showed that the reduction of plasma glycolithocholic acid and taurolithocholic acid could contribute to the immunosuppression of monocytes (CD14 + MON) during excessive lipolysis by decreasing the expression of GPBAR1 . (biomedcentral.com)
  • ICE Pharma are able to supply these conjugates to a host of bile acids and we are able to conjugate alternative amino acids to provide custom products as required. (thebileacidsexpert.com)
  • Just about all rights set-aside.The goal of the analysis was to determine the actual amino acid structure in fillet proteins regarding newly carefully bred hand mirror carp collections. (kspinhibitors.com)
  • Lastly, metabolic profiling showed that arachidonic acid, prostaglandins, and palmitic acid were enriched at 48H. (nature.com)
  • To the best of our knowledge, short-chain fatty acids (SCFAs), bile salt hydrolase (BSH), metabolic endotoxemia and the endocannabinoid (eCB) system are essential in regulating the initiation and progression of MS through the normalization of adipogenesis and the regulation of insulin secretion, fat accumulation, energy homeostasis, and plasma cholesterol levels. (biomedcentral.com)
  • In recent years, bile acids and their derivatives have received considerable interest in drug delivery research due to their versatile role in pharmaceutical formulations. (viochemicals.com)
  • In Glycodeoxycholic Acid-d4 custom synthesis contrast, DARPin is well-expressed inside the cells [45], particularly AnkGAG 1D4, together with the domain essential for capsid polymorphism [21]. (calpaininhibitor.com)
  • Besides PCSK9 limiting entry of LDL-derived cholesterol, affecting multiple cholesterol-related functions in cells, more recent studies have associated PCSK9 with various other cellular processes, including inflammation, fatty acid metabolism, cancerogenesis and visceral adiposity. (bvsalud.org)
  • Because of abnormal gut mucosa and altered gut microbiome, EED could potentially affect the metabolism and enterohepatic circulation of bile acids. (johnshopkins.edu)
  • Conclusions: EED is associated with altered bile acid metabolism in young children in rural Malawi. (johnshopkins.edu)
  • The availability and low cost of bile acids along with their unique advantages turn them into attractive scaffolds for the design of novel drugs and drug carrier systems. (viochemicals.com)
  • Consistently, high amounts of primary bile acids as well as sterols were found in their feces. (biomedcentral.com)
  • The goal of this minireview is to provide an update on the regulation of bile acid (BA) homeostasis by the nuclear receptor Farnesoid X receptor (FXR) and the effects on this regulation by exposure to environmental or therapeutic agents. (aspetjournals.org)
  • Maintaining bile acid (BA) homeostasis is important and regulated by BA activated receptors and signaling pathways. (aspetjournals.org)
  • The aim of this study was to investigate the influence of N-acetylcysteine (NAC) on acute necrotizing pancreatitis (ANP) induced by glycodeoxycholic acid in rats. (ktu.edu.tr)
  • Glycodeoxycholic acid is a bile acid derived from deoxycholic acid and glycine. (wikipedia.org)
  • Compared to controls or non-LDSD patients, LDSD patients had a featured fecal BA profile, with higher proportions of deoxycholic acid (DCA), 7-ketodeoxycholic acid, and lithocholic acid. (biomedcentral.com)
  • Secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) are produced in the colon by bacterial dehydroxylation of the primary BAs. (pancreapedia.org)
  • Previous studies have implicated hydrophobic bile acids and gastric acid in BE and EAC pathogenesis. (nih.gov)
  • In the liver, bile-acids are synthesized from cholesterol and are conjugated to either glycine or taurine to form amphipathic molecules capable of fat emulsification upon secretion into the duodenum. (medscape.com)
  • Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells. (nih.gov)
  • In this study, we tested the hypothesis that DNA damage, cytotoxicity and oxidative stress induced by bile acids and gastric acid can be attenuated by the cytoprotective, hydrophilic bile acid glycoursodeoxycholic acid (GUDCA). (nih.gov)
  • Higher serum bile acid levels are associated with an increased risk of cirrhosis and liver-related morbidity and mortality. (nih.gov)
  • Additionally, BBR functions to reduce serum cholesterol by up-regulating the conversion of cholesterol into bile acids which are excreted at higher levels in feces [4,5]. (researchsquare.com)
  • Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study[J]. Journal of Zhejiang University Science B, 2021, 22(10): 856-865. (zju.edu.cn)
  • Objective This study evaluated the prognostic power of serum uric acid (UA) in predicting adverse events in elderly acute coronary syndrome (ACS) patients with diabetes mellitus (DM). (zju.edu.cn)
  • Serum bile acid as glycodeoxycholic acid tenderness is a common and observer-rated Testosterone Enanthate for sale mood well-known for its anabolic properties. (swop-chicago.org)
  • Non-dysplastic BE cells were exposed for 10 min to pH 4 and/or bile acid cocktail or to pH 4 and a modified cocktail consisting of a mixture of bile acids and GUDCA. (nih.gov)
  • Bile Acid Factors ® consists of a mixture of highly-concentrated bile acids (also called bile salts), mostly in the conjugated form, from U.S. and/or New Zealand bovine/ovine bile. (jarrow.hk)
  • Abnormal exposure of esophageal cells to a mixture of acid and bile salts in patients with chronic gastroesophageal reflux disease (GERD) is a major risk factor for the development of pre-malignant Barrett's esophagus (BE) and its progression to EAC [ 3 , 4 ]. (biomedcentral.com)
  • Herein, we report secondary analyses of aldafermin, an engineered analogue of the gut hormone fibroblast growth factor 19, on the circulating bile acid profile in prospective, phase II studies in patients with metabolic or cholestatic liver disease. (nih.gov)
  • Dysregulation of gut microbiota-host bile acid (BA) co-metabolism is a critical pathogenic factor of diarrhea-predominant irritable bowel syndrome (IBS-D). Traditional Chinese Medicine (TCM), instructed by pattern differentiation, is effective in treating IBS-D, in which liver depression and spleen deficiency (LDSD) is the most prevalent pattern. (biomedcentral.com)
  • Bile acids are produced in the liver and then stored and concentrated in the gallbladder, from which they enter the small intestines via the bile duct. (jarrow.hk)
  • The major BAs in humans are chenodeoxycholic acid (CDCA) and cholic acid (CA), which are known as primary BAs since they are synthesized in the liver (46). (pancreapedia.org)
  • [ 97 ] Unconjugated bile-acids are themselves potent inhibitors of microbial proliferation, thus intestinal BSH positive bacteria usually exploit further enzymatic, transport or precipitation methods [ 98-100 ] to eliminate the inhibitor from their immediate environment. (medscape.com)
  • Bile is a viscous alkaline fluid consisting of bile salts, bile pigments, bile acids, cholesterol and phospholipids. (medscape.com)
  • Reduction in lipids, particularly cholesterol, is achieved partly through up-regulation of bile acid synthesis and excretion into the gastrointestinal tract (GI). (researchsquare.com)
  • Multi-omics (bile acid metabolomics, 16S rDNA sequencing, cecal metatranscriptomics) were performed in order to provide a simple in vivo model from which to identify network-based correlations between bile acids and bacterial transcripts in the presence and absence of dietary BBR. (researchsquare.com)
  • Digestive enzymes, stomach acid, defensin secretion and bile production contribute to the antimicrobial arsenal developed by mammalian hosts to inhibit microbial colonization and potential infection. (medscape.com)
  • Minimum inhibitory concentrations of bile or conjugated bile acids varied among strains of the same BSH-1 group, but this was not due to differential transcription of the bsh-1 gene in different strains. (medscape.com)
  • Bile acid concentrations in the GI tract increased significantly during BBR treatment and developed extensive correlation networks with expressed genes in the B4PC2 community. (researchsquare.com)
  • IBS-D can be triggered by multiple external and internal factors, which include an excess of irritants, e.g., bile acids (BAs), exposure in the colon [ 10 , 11 ]. (biomedcentral.com)
  • In addition, bile acid deficiency reduces the absorption of fat and fat-soluble nutrients. (jarrow.hk)
  • DNA damage and oxidative stress were significantly increased, while thiol levels were decreased in BE cells treated with pH 4 and bile acid cocktail compared with cells treated with pH 4 alone or untreated cells. (nih.gov)
  • Bile acids and low pH also significantly decreased cell proliferation. (nih.gov)
  • Reduced glycodeoxycholic acid levels. (zju.edu.cn)
  • Distinguishing indirect effects of BBR on bacteria through altered bile acid profiles is particularly important in understanding how dietary nutraceuticals alter the microbiome. (researchsquare.com)
  • Expression of the antioxidant enzymes, MnSOD and CuZnSOD, was elevated in the cells treated with bile acids and low pH. (nih.gov)
  • Unfortunately, we do not know the concentration of bile acids that can reach the pancreatic ductal cells under pathological conditions. (pancreapedia.org)
  • The major bile components in Bile Acid Factors ® are glycocholate and taurocholate, which are crucial for fat absorption. (jarrow.hk)

No images available that match "glycodeoxycholic acid"